GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, APEX1, AR, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, GPER1, GRIK5, GRM5, HSD17B2, IDO1, IGF1R, MMP2, MMP9, PPARA, RORC, SRC, TYR |
8.41209 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPI, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MET, MIF, PPARA |
8.15415 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CA12, CA2, CA7, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HSD11B1, HSD17B1, HSD17B2, HSD17B3, KDR, MET, MIF, PPARA, SLC1A1, SRC, TNKS, TNKS2, XDH |
7.74385 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GPER1, GRIK5, IDO1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTPN1, SRC, TOP2A, XDH |
7.36995 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GPER1, GRIK5, IDO1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, SRC, TOP2A, XDH |
7.29166 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD17B2, IDO1, RORC, SRC, TYR |
7.19036 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
7.19036 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AKR1C3, APEX1, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM5, HSD17B2, IDO1, IGF1R, KDR, MMP2, PPARA, RORC, SRC, TYR |
7.19036 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FUT7, GLO1, HSD17B3, IDO1, MIF, PIM1, PPARA, TYR, XDH |
7.15419 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
7.15366 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
6.8238 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GLO1, GPER1, GRIK5, IDO1, IGF1R, KDR, MIF, MMP9, PIM1, PTPN1, SRC, TOP2A, XDH |
6.8238 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.8148 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.8148 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, GRIK5, GRM1, GRM5, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
6.8148 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1, TYR |
6.38013 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PIM1, PPARA, RORC, SRC |
6.36008 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TNKS, TNKS2, TOP2A, XDH |
6.36008 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC, SRC |
6.2311 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IDO1, TYR, XDH |
6.01249 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, AKR1C3, APEX1, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM5, HSD17B2, IDO1, IGF1R, KDR, MMP2, MMP9, PPARA, RORC, SRC, TYR |
6.01249 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
5.93359 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.77914 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, KDR, PPARA, SRC, TYR |
5.73646 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, APEX1, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, GPER1, RORC, SRC, TYR |
5.67358 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, GLO1, HSD17B3, IDO1 |
5.60383 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AKR1C3, AR, CDC25B, CSNK2A1, CYP1B1, ESR1, ESRRA, FABP3, FLT3, GPER1, IDO1, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, SRC, XDH |
5.59975 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AKR1C3, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GPER1, GRM1, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
5.54896 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AKR1C3, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, FLT3, GPER1, GRM1, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
5.52343 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, AKR1C3, APEX1, AR, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, GRM5, IGF1R, MMP2, PPARA, SRC |
5.49447 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC, SRC |
5.44562 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AKR1C3, APEX1, AR, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, PPARA, SRC |
5.40634 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.11836 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CA2, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B2, HSD17B3, KDR, MET, MIF, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TNKS2, TOP2A, TYR |
5.07111 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, GPER1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
5.00396 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPER1, GRM3, GRM8, IDO1, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
4.98951 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, IDO1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PTPN1, SRC |
4.98159 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AKR1C3, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
4.98159 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AKR1C3, AR, AURKB, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, FLT3, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
4.86622 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPI, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
4.83564 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPI, AR, AXL, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, FABP4, GPER1, GRM1, GRM5, GRM8, HSD17B2, IDO1, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TNKS2, TYR |
4.76397 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, IDO1, IGF1R, KDR, MET, MIF, MMP9, PIM1, PTPN1, SRC |
4.75564 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APEX1, AR, AXL, CYP1B1, ESR1, GPER1, GRIK5, GRM5, IGF1R, MMP2, MMP9, RORC, SRC |
4.7554 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MIF |
4.74832 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, APEX1, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, SRC |
4.60916 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MIF |
4.57014 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.48474 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.48474 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, MMP9, SRC |
4.47488 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, IGF1R, KDR, MIF, MMP2, MMP9, PTPN1, RORC, SRC, TOP2A |
4.43241 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AKR1C3, APEX1, AR, AXL, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM5, IGF1R, KDR, MMP2, MMP9, RORC, SRC |
4.38738 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.38636 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AKR1C3, APEX1, AR, AXL, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM5, IGF1R, KDR, MMP2, RORC, SRC |
4.30327 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, AR, AXL, CSNK2A1, CYP1B1, FLT3, GPER1, GRM1, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
4.26814 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX5, ALPI, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, MET, MIF, PPARA |
4.23177 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AKR1C3, AR, AXL, CSNK2A1, CYP1B1, ESRRA, FABP4, FLT3, GPER1, GRM1, IDO1, KDR, MET, MIF, MMP12, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
4.20863 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, GLO1, IDO1, IGF1R, KDR, MIF, MMP9, PIM1, PTPN1, SRC |
4.14334 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPI, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP2, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
4.09342 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
4.07076 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPER1, GRM3, GRM8, IDO1, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
4.0672 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AKR1C3, AR, CDC25B, CSNK2A1, ESR1, FLT3, GPER1, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1 |
3.97339 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1, HSD17B3 |
3.969 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, APEX1, AR, CYP1A1, CYP1B1, ESR1, FLT3, GPER1, RORC, SRC |
3.95481 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, ALPI, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MIF |
3.89147 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AKR1C3, AR, AURKB, CDC25B, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
3.81043 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, CA1, CSNK2A1, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2 |
3.70361 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AKR1C3, AR, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
3.68647 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, IDO1, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.67875 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, IDO1, MIF, PPARA |
3.67119 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, MIF, PPARA |
3.64279 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, AR, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
3.60996 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, MIF |
3.55524 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, CBR1, CYP1A1, CYP1A2, CYP1B1 |
3.54147 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, AR, AXL, CYP1B1, FLT3, GPER1, GRM1, KDR, MET, MIF, PTPN1, SRC, XDH |
3.52499 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.51906 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.4873 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, AR, CDC25B, ESRRB, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MIF, MMP9, PPARA, PTPN1, SRC, XDH |
3.46991 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AKR1C3, AR, AXL, CA1, CA2, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2 |
3.45527 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, AR, CDC25B, ESRRB, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MIF, MMP9, PPARA, PTPN1, SRC, XDH |
3.4236 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, HSD17B2, IDO1, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SRC, TOP2A, TYR |
3.3971 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
3.39124 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
3.38746 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.36246 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.36246 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.36246 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPI, AOX1, APEX1, AR, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
3.32407 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, AR, AURKB, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
3.32407 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, MMP9, SRC |
3.30021 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, FLT3, GPER1, GRM1, IGF1R, KDR, MET, MIF, MMP9, PTPN1, SRC, XDH |
3.21984 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.2085 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AKR1C3, APEX1, AR, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GPER1, GRM3, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
3.16873 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, AXL, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, MET, SRC |
3.13818 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.06818 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.06818 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AR, AXL, CYP19A1, ESR1, HSD17B2, HSD17B3, SRC |
3.06526 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
3.06526 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, AKR1C3, CYP1A1, FABP3, FLT3, GPER1, PPARA, RORC, SRC |
3.04436 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, MMP9, SRC |
3.02176 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
2.99789 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, AR, CDC25B, ESRRB, FABP3, FLT3, GPER1, GRM1, GRM5, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.99789 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, AR, CDC25B, ESRRB, FABP3, FLT3, GPER1, GRM1, GRM5, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.99789 |
[BP] GO:0071383 |
None
|
AKR1C3, AR, FLT3, GPER1, SRC |
2.98559 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, GPER1, KDR, MIF, SRC, TNKS, TNKS2 |
2.98327 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
2.97208 |
[BP] GO:0007193 |
None
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
2.94147 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
2.91649 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AKR1C3, APEX1, AR, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GPER1, GRM3, GRM8, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
2.9116 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.90781 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, SRC |
2.90226 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, AR, CDC25B, ESRRB, FLT3, GPER1, GRM1, GRM5, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.89517 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, IDO1, MIF, PIM1, PPARA, TYR |
2.86952 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.85335 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, MIF |
2.81384 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.77998 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
2.77998 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
2.77998 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
2.77998 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.77998 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
2.77998 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC, TNKS |
2.77756 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, AR, FLT3, GPER1, GRM1, KDR, MIF, PTPN1, SRC, XDH |
2.77438 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.74206 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.70133 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPI, AOX1, APEX1, AR, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.68406 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, AR, CDC25B, ESRRB, FABP4, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MIF, MMP9, PPARA, PTPN1, SRC, XDH |
2.68406 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, GPER1, IGF1R, KDR, MET, MIF, MMP9, SRC |
2.66782 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, IDO1 |
2.6671 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, AR, AXL, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD17B2, HSD17B3, IDO1, MMP2, MMP9, SRC, TOP2A |
2.64538 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, ESR1, FLT3, MET, MIF, PIM1, SRC, TYR |
2.62554 |
[BP] GO:0007188 |
None
|
ADORA1, GPER1, GRM1, GRM3, GRM5, GRM8 |
2.61379 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, SLC1A1 |
2.5663 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.54764 |
[BP] GO:2000107 |
negative regulation of leukocyte apoptotic process
|
AURKB, AXL, IDO1, MIF |
2.54764 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
2.53401 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, GPER1, GRIK5, GRM5, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PTPN1, SRC |
2.53165 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, AR, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, KDR, MMP9, PIM1, PPARA, RORC, SRC, TYR |
2.51312 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, AR, CDC25B, FLT3, GPER1, GRM1, GRM5, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.50448 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, IDO1, MIF, PIM1, PPARA, TYR |
2.49726 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AKR1C3, APEX1, AR, ESR1, FLT3, GPER1, GRM5, IGF1R, MMP2, SRC |
2.482 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.482 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, CBR1, CYP1A1, CYP1A2, CYP1B1 |
2.482 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APEX1, AR, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TNKS, TNKS2, TOP2A, XDH |
2.4657 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, GPER1, IGF1R, KDR, MET, MIF, MMP9, SRC |
2.44706 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, FABP3, GLO1, IDO1, MIF, PIM1, PPARA, TYR |
2.43531 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, GPER1, GRM5, IGF1R, PPARA, SRC |
2.43053 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.42492 |
[BP] GO:0051172 |
None
|
APEX1, AR, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GPER1, GRM3, GRM8, IGF1R, MIF, MMP12, MMP9, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
2.42492 |
[BP] GO:0045934 |
None
|
APEX1, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, GPER1, GRM3, GRM8, MMP12, PPARA, RORC, SRC, TNKS, TNKS2 |
2.42337 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, PPARA, SRC |
2.41645 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, GRM5, MIF, PTPN1, SRC |
2.41645 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, AKR1C3, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, FABP4, FLT3, GPER1, GRM1, IDO1, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
2.4086 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.4086 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.4086 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.4086 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.4086 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, APEX1, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GPER1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
2.40731 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.40561 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.40536 |
[BP] GO:0071396 |
cellular response to lipid
|
AKR1C3, AR, AXL, ESR1, FLT3, GPER1, RORC, SRC |
2.40536 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1 |
2.39024 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.37732 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, AKR1C3, APEX1, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GPER1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
2.37732 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, AR, FLT3, GPER1, GRM1, IGF1R, KDR, MIF, PTPN1, SRC, XDH |
2.35458 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, APEX1, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, GPER1, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A, XDH |
2.3382 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, KDR, MET, MMP12, PPARA, RORC, SRC, TNKS, TNKS2, TOP2A |
2.3368 |
[BP] GO:0007187 |
None
|
ADORA1, GPER1, GRM1, GRM3, GRM5, GRM8 |
2.32688 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, AR, AXL, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSD17B3, SRC |
2.31149 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.29521 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.28021 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, KDR, MET, MMP12, PPARA, RORC, SRC, TNKS, TNKS2, TOP2A |
2.26463 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.26224 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.2621 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.23517 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.22699 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPI, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.22183 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.21424 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.20842 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, ESR1, PPARA, RORC, SRC, TOP2A |
2.20842 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, GPER1, IGF1R, KDR, MET, MIF, MMP9, SRC |
2.20842 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.20309 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, GPER1, IGF1R, KDR, MET, MIF, MMP9, SRC |
2.19806 |
[BP] GO:0010675 |
None
|
ESRRB, GPER1, PPARA, RORC, SRC |
2.18953 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.18948 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.18948 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.18948 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.18948 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.18948 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, FABP3, FLT3, GPER1, GRM5, IGF1R, MMP2, PPARA, SRC, TYR |
2.18808 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.16222 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.1477 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1 |
2.14506 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.14256 |
[BP] GO:0006081 |
None
|
AKR1B10, AKR1C3, CYP1B1, GLO1 |
2.14256 |
[BP] GO:0042391 |
None
|
ADORA1, GPER1, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
2.13512 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, AR, CDC25B, FABP4, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MIF, MMP9, PTPN1, SRC, XDH |
2.1328 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
ESR1, GPER1, IGF1R, MET, MIF, MMP9, PTPN1, SRC, XDH |
2.1293 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, MET, MMP12, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TOP2A |
2.1293 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, ESR1, FABP4, GPER1, IDO1, KDR, MET, MIF, MMP12, PPARA |
2.09185 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, GPER1, GRM5, IGF1R, SRC |
2.09185 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, GPER1, KDR, SRC |
2.09185 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, PPARA, SRC |
2.07905 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, ESR1, FABP4, GPER1, IDO1, MMP12, MMP2, PPARA, PTPN1, SRC |
2.07691 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, AR, AURKB, CDC25B, ESR1, ESR2, FLT3, GPER1, GRM1, GRM5, MET, MIF, MMP9, PTPN1, SRC, TNKS, XDH |
2.069 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.069 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.069 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, GPER1, MET, SRC, XDH |
2.069 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, AR, AURKB, CDC25B, CSNK2A1, ESR1, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, IGF1R, MIF, MMP9, PTPN1, SRC, TNKS, XDH |
2.06829 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.06711 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, AR, AURKB, AXL, CSNK2A1, CYP1B1, ESR1, ESR2, FLT3, GPER1, GRM1, IGF1R, KDR, MET, MIF, MMP12, MMP9, PTPN1, SRC, TNKS, TNKS2, XDH |
2.06379 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, CYP1A1, CYP1B1, HSD17B3, TYR |
2.0592 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, ESR1, FABP3, FABP4, GPER1, GRIK5, GRM1, GRM5, MET |
2.02848 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.02848 |
[BP] GO:0030263 |
None
|
GPER1, TOP2A |
2.01267 |
[CC] GO:0042734 |
None
|
GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.57014 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, SLC1A1, SRC |
3.51906 |
[CC] GO:0014069 |
None
|
ADORA1, GPER1, GRIK5, GRM1, GRM3, GRM5, SRC |
2.98559 |
[CC] GO:0099572 |
None
|
ADORA1, GPER1, GRIK5, GRM1, GRM3, GRM5, SRC |
2.98559 |
[CC] GO:0097060 |
None
|
GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.91467 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC |
2.43084 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, AOX1, APEX1, AR, AURKB, AXL, CA1, CA2, CA4, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GPER1, GRIA4, GRIK5, GRM1, GRM5, HSD17B3, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SHBG, SLC1A1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.3095 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALPI, AR, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, ESR1, FLT3, GLO1, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, PIM1, PTPN1, SLC1A1, SRC |
2.2173 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, AOX1, APEX1, AR, AURKB, AXL, CA1, CA2, CA4, CA9, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GLO1, GPER1, GRIA4, GRIK5, GRM1, GRM3, GRM5, HSD17B3, IDO1, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SHBG, SLC1A1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
2.18948 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, ALPI, AOX1, AR, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH |
14.9226 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.42984 |
[MF] GO:0008270 |
zinc ion binding
|
ALPI, AR, CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, TNKS |
8.54129 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.78174 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPI, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IDO1, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PTPN1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
7.77112 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
7.77112 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
7.77112 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD17B1, RORC, SHBG |
7.39385 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PPARA, RORC |
7.28352 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, CBR1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, XDH |
7.19036 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, IDO1, TYR, XDH |
7.18637 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPI, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, GLO1, HSD17B1, IDO1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, SRC, TNKS, TNKS2, TOP2A, TYR, XDH |
6.88308 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.72282 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.1974 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, RORC |
6.14136 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPI, AOX1, APEX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, IDO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, TNKS, TNKS2, TOP2A, TYR, XDH |
5.99737 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPI, AOX1, APEX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, IDO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SLC1A1, TNKS, TNKS2, TOP2A, TYR, XDH |
5.68125 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, CBR1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
5.36111 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, RORC |
5.34014 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.11836 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, RORC |
5.11494 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
4.86622 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
4.74175 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AR, AXL, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, PPARA, RORC |
4.69776 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
3.969 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
3.92673 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, GPER1, HSD17B1, IGF1R, SHBG |
3.86012 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, HSD17B1, PPARA, RORC, SHBG |
3.80243 |
[MF] GO:0047035 |
testosterone dehydrogenase (NAD+) activity
|
AKR1C3, HSD17B2, HSD17B3 |
3.70361 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
3.61456 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.57648 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.4873 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.3971 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, XDH |
3.36246 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.31236 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, SRC |
2.99789 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.90226 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.88206 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, SRC |
2.85775 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
2.77998 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.77998 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
2.62554 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.61379 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
2.5701 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET |
2.482 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET |
2.482 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.4086 |
[MF] GO:0047045 |
None
|
AKR1C3, HSD17B3 |
2.4086 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.4086 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.39024 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.39024 |
[MF] GO:0030594 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.36106 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.34766 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, HSD17B1, IDO1, SRC, XDH |
2.29521 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.18948 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.18948 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.18948 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.069 |